Titlebook: Rechtliche und ethische Probleme bei klinischen Untersuchungen am Menschen; Hans Klaus Breddin,Erwin Deutsch,Hans J. Jesdinsky Conference

显示全部楼层 · 发表于 2025-3-27 07:37:22

H. J. Gaertner,H. Heimannving the negative regulation over T cells [6–8]. Recent FDA approval of CAR-T therapy (chimeric antigen receptor T-cell therapy by genetically engineered T cells for antigen‐specific tumor therapy) for B‐cell and non‐Hodgkin lymphoma therapy is also emerging news in the immunotherapy field [9, 10].

显示全部楼层 · 发表于 2025-3-27 12:11:00

H. Rauscheckerving the negative regulation over T cells [6–8]. Recent FDA approval of CAR-T therapy (chimeric antigen receptor T-cell therapy by genetically engineered T cells for antigen‐specific tumor therapy) for B‐cell and non‐Hodgkin lymphoma therapy is also emerging news in the immunotherapy field [9, 10].

显示全部楼层 · 发表于 2025-3-27 13:55:03

显示全部楼层 · 发表于 2025-3-27 18:26:11

Hans Klaus Breddin,Erwin Deutsch,Hans J. Jesdinsky

显示全部楼层 · 发表于 2025-3-27 23:44:59

MedR Schriftenreihe Medizinrechthttp://image.papertrans.cn/r/image/823854.jpg

显示全部楼层 · 发表于 2025-3-28 03:43:38

显示全部楼层 · 发表于 2025-3-28 06:38:44

显示全部楼层 · 发表于 2025-3-28 13:37:26

		自动登录	找回密码
密码			To register

关于派博传思			派博传思旗下网站			友情链接
派博传思介绍	公司地理位置	论文服务流程	影响因子官网	SITEMAP	大讲堂	北京大学	Oxford Uni.	Harvard Uni.
发展历史沿革	期刊点评	投稿经验总结	SCIENCEGARD	IMPACTFACTOR	派博系数	清华大学	Yale Uni.	Stanford Uni.
\|Archiver\|手机版\|小黑屋\| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-6-10 15:54
Copyright © 2001-2015 派博传思京公网安备110108008328 版权所有 All rights reserved

Titlebook: Rechtliche und ethische Probleme bei klinischen Untersuchungen am Menschen; Hans Klaus Breddin,Erwin Deutsch,Hans J. Jesdinsky Conference

浏览过的版块